Basic Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Feb 21, 2015; 21(7): 2030-2039
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2030
Table 1 Preclinical studies of mesenchymal stem cells therapy for inflammatory bowel disease
Ref.ModelInduction methodMSC sourceDoseInjection routeTimeCharacteristicOutcome
Kim et al[11]C57BL/62% DSSXenogeneic: Rat (Sprague-Dawley) BM1 × 105sc0, 3, 6 dIL-12p40-transducedPositive
6, 9, 12 d
He et al[10]BALB/c4% DSSSyngeneic: Mouse (BALB/c) BM1 × 106iv2, 5, 8 dMultiple injectionPositive
Parekkadan et al[12]C57BL/6 RAG-1-/-CD4+CD45RBhi 5 × 105Allogeneic: Mouse (Aire-/-) BM2.5 × 105iv0, 3 wkAire-/- injectionPositive
iv injection
Ko et al[9]C57BL/65% DSSAllogeneic: Mouse (C57BL-10 × CBA/CA) BM1 × 106iv2 dMAdCAM-1- VCAM-1-Ab-coatedPositive
Gonzalez-Rey et al[49]C57BL/6a: 5% DSSXenogeneic: Human adiposea: 1-50 × 105 hMSC, 1 × 106 mMSC c: 1 × 106 hMSCipa: 2 dhMSCPositive
c: 3% DSSSyngeneic: Mouse (C57BL/6) BMc: 7 d of each cycle
Allogeneic: Mouse (BALB/c) BM
Table 2 Clinical trials of adipose-derived stem cells and mesenchymal stem cells inflammatory bowel disease therapies
Ref.DiseasePhaseNo. of patientsStem cell sourceRouteOutcome
de la Portilla et al[15]Complex perianal fistulaI/II24ASC; Allo-adiposeIntralesionalImproved
Lee et al[20]Crohn’s fistulaII43ASC; Allo-adiposeIntralesionalImproved
Cho et al[13]Crohn’s fistulaI10ASC; Allo-adiposeIntrafistulaImproved
Herreros et al[19]Complex cryptoglandular perianal fistulaIII200ASC; Allo-adiposeIntrafistulaImproved
Guadalajara et al[18]Complex perianal fistulaII24ASC; Allo-liposuctionIntrafistulaImproved
Ciccocioppo et al[14]Crohn’s fistulaI/II12MSC; Allo-BMIntrafistulaImproved
Garcia-Olmo et al[17]Complex perianal fistulaII14ASC; Auto-adiposeIntrafistulaImproved
García-Olmo et al[16]Crohn’s fistulaI10ASC; Allo-adiposeIntrafistulaImproved